Bifemelane
Bifemelane is a nootropic compound. Bifemelan causes the first peak by stimulating release from intracellular Ca2+ stores and the second by capacitive entry through store–operated Ca2+ channels. Bifemelane will be provided as a pharmacological tool for basic studies on astrocytes[1].
Product Specifications
CAS Number
[90293-01-9]
Product Name Alternative
MCI-2016 (free base)
UNSPSC
12352005
Hazard Statement
H315-H319
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bifemelane.html
Solubility
10 mM in DMSO
Smiles
CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2
Molecular Formula
C18H23NO
Molecular Weight
269.38
Precautions
P264-P280-P302+P352-P305+P351+P338-P362+P364
References & Citations
[1]YoshitokuYoshida, et al. A Novel Effect of Bifemelane, a Nootropic Drug, on Intracellular Ca2+ Levels in Rat Cerebral Astrocytes.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MAPK10 (Mitogen-Activated Protein Kinase 10, FLJ12099, FLJ33785, JNK3, JNK3A, MGC50974, PRKM10, p493F12, p54bSAPK) (MaxLight 750) discontinued
